Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-19

Clinical Trial Update: Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates ongoing evaluation of tirofiban for preventing neurological deterioration in acute ischemic stroke across phase 2 and phase 3 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tirofiban (tirofiban)

Snippet

Sponsor: Capital Medical University | Conditions: Acute Stroke | Phase 2, Phase 3 | Status: UNKNOWN